Escoublac Inc. Lands $6,650,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Escoublac Inc.
  • Mailing Address
    14 Cambridge Center Cambridge, MA 02142
  • Company Description
    Escoublac was established based on the discovery that osteocalcin, a protein found in bone and dentin, plays a role in energy metabolism and related disorders. The research findings, published in the August 2007 issue of the peer-reviewed scientific journal Cell, demonstrated that osteocalcin encouraged weight loss, increased the production of insulin-generating beta cells as well as insulin, and improved sensitivity to insulin. The company aims to transform this discovery into new therapies for metabolic disorders and related conditions, such as obesity and type 2 diabetes.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy